Control of hypertension in South Africa: Time for action

South African Medical Journal

Volumn 102, Issue 1, 2012, Pages 25-26

  Seedat, Y K ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; EDITORIAL; HEALTH INSURANCE; HUMAN; HYPERTENSION; MORTALITY; PREVALENCE; PRIMARY HEALTH CARE; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; SOUTH AFRICA;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; GOLD; HUMANS; HYPERTENSION; MALE; MINING;

EID: 84255166531     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005;355:217-223.
2. Neal B, Chapman N, Patel A. Managing the global burden of cardiovascular disease. Eur Heart J Suppl 2002;4(F):F2-F6.
3. Seedat YK. Hypertension in developing nations in sub-Saharan Africa. J Hum Hypertens. 2000;14:739-747.
4. MacMahon S, Alderman MH, Lindholm LH, et al. Blood-pressure-related disease is a global health priority. Lancet 2008;26(10):2071-2072.
5. Maepe LM, Outhoff K. S Afr Med J 2012.
6. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601.
7. st century. New York: Oxford University Press,1999.
8. Hypertension guideline. S Afr Med J 2012.
9. Egan BM, Zhao Y, Axon BN. US trends in prevalence. Awareness, treatment and control of hypertension, 1988 - 2008. JAMA 2010;303:2043-2050.
10. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, Treatment intensification and control in Western Europe and the United States. Arch Intern Med 2007;167:141-147.